Quince Therapeutics

0.5602
+0.4302
+330.92%
QNCX
高 0.6520开 0.2834量 13.83亿股总市值 3119.28万
低 0.2459换 2484.48%额 4.80亿市盈TTM 亏损
分时
5日
日K
周K
月K
季K
年K
  • MA
  • BOLL
  • 成交量
  • MACD
  • KDJ
  • RSI
  • WR
  • BIAS
  • CCI
  • PSY
讨论
资讯
公告
资料
财务
相关
用户头像
Quince Therapeutics(QNCX)
2025-12-13 06:15  
$Quince Therapeutics(QNCX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000912282-25-001407  Size: 6 KB 网页链接
用户头像
Quince Therapeutics(QNCX)
01-30 05:45  
$Quince Therapeutics(QNCX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-26-029524  Act: 34  Size: 169 KB 网页链接
用户头像
Quince Therapeutics(QNCX)
01-22 07:15  
$Quince Therapeutics(QNCX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000912282-26-000089  Size: 5 KB 网页链接
用户头像
Quince Therapeutics(QNCX)
2025-12-30 06:45  
$Quince Therapeutics(QNCX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000912282-25-001468  Size: 5 KB 网页链接
用户头像
Quince Therapeutics(QNCX)
2025-12-30 06:45  
$Quince Therapeutics(QNCX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000912282-25-001469  Size: 5 KB 网页链接
用户头像
Quince Therapeutics(QNCX)
2025-12-30 06:55  
$Quince Therapeutics(QNCX)$ 144 Report of proposed sale of securities Accession Number: 0001628280-25-059050  Act: 33  Size: 4 KB 网页链接
用户头像
Quince Therapeutics(QNCX)
2025-11-15 05:45  
$Quince Therapeutics(QNCX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001104659-25-112623  Act: 34  Size: 11 KB 网页链接
用户头像
Quince Therapeutics(QNCX)
01-22 07:05  
$Quince Therapeutics(QNCX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000912282-26-000083  Size: 5 KB 网页链接
用户头像
Quince Therapeutics(QNCX)
01-24 09:15  
$Quince Therapeutics(QNCX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000912282-26-000119  Size: 5 KB 网页链接
用户头像
Quince Therapeutics(QNCX)
01-22 07:15  
$Quince Therapeutics(QNCX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000912282-26-000087  Size: 5 KB 网页链接
用户头像
Quince Therapeutics(QNCX)
01-24 09:15  
$Quince Therapeutics(QNCX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000912282-26-000120  Size: 5 KB 网页链接
用户头像
Quince Therapeutics(QNCX)
2025-12-08 21:15  
$Quince Therapeutics(QNCX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000912282-25-001370  Size: 10 KB 网页链接
用户头像
Quince Therapeutics(QNCX)
01-22 07:15  
$Quince Therapeutics(QNCX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000912282-26-000085  Size: 5 KB 网页链接
用户头像
Quince Therapeutics(QNCX)
02-03 05:35  
$Quince Therapeutics(QNCX)$ 8-K Current report, item 5.02 Accession Number: 0001193125-26-033758  Act: 34  Size: 135 KB 网页链接
用户头像
Quince Therapeutics(QNCX)
2025-11-13 05:15  
$Quince Therapeutics(QNCX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-25-277529  Act: 34  Size: 12 MB 网页链接
用户头像
Quince Therapeutics(QNCX)
2025-11-13 05:16  
$Quince Therapeutics(QNCX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-25-277523  Act: 34  Size: 477 KB 网页链接
用户头像
Quince Therapeutics(QNCX)
01-24 09:35  
$Quince Therapeutics(QNCX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000912282-26-000121  Size: 5 KB 网页链接